Nano-cap New Highs: EveryWare Global (NASDAQ:EVRY), China Auto Logistics (NASDAQ:CALI), NetSol Technologies Inc. (NASDAQ:NTWK), MELA Sciences Inc (NASDAQ:MELA)

EveryWare Global, Inc.(NASDAQ:EVRY) announced financial results for the last three months and full year for 2013. Led by the iconic Oneida and Anchor Hocking brands, EveryWare is the leading global marketer of tabletop and food preparation products for the consumer and foodservice markets. EveryWare Global, Inc.(NASDAQ:EVRY) stock performance was 10.31%in last session and finished the day at $ 2.00. Traded volume was 65,045 shares in the last session and the average volume of the stock remained 107,128 shares. The beta of the stock remained -1.630. EveryWare Global, Inc.(NASDAQ:EVRY) insider ownership is 0.50%.

China Auto Logistics Inc (NASDAQ:CALI) a top seller in China of luxury imported automobiles, and a leading provider of auto-related services, reported today a lower year over year small profit for the year ended December 31, 2013, as it sought to maintain leadership in China’s highly competitive luxury imported vehicle market. China Auto Logistics Inc (NASDAQ:CALI) dropped -20.51% percent to $ 1.86 yesterday on volume of 83,566.00 shares. The intra-day range of the stock was $ 1.83 – 2.27. China Auto Logistics Inc (NASDAQ:CALI) has a market capitalization of $ 7.50 million.

Netsol Technologies (NASDAQ:NTWK)’s shares were upgraded by Zacks from an underperform rating to a neutral rating in a report issued on Tuesday, AnalystRatings.NET reports. They currently have $4.40 target price on the stock. (NASDAQ:NTWK)’s stock on May 7, 2014 reported a decrease of -5.79% to the closing price of $ 3.74. Its fifty two weeks range is $ 3.68 – 12.55. The total market capitalization recorded $ 34.22 million. The overall volume in the last trading session was 146,026.00 shares. In its share capital, NetSol Technologies Inc. (NASDAQ:NTWK) has 9.15 million outstanding shares.

MELA Sciences Inc (NASDAQ:MELA) developer of the MelaFind® system, an optical diagnostic device approved for use in the U.S. and the European Union to assist dermatologists in melanoma diagnosis, will release its first quarter 2014 financial results and provide an update on its activities on Tuesday, May 13, 2014, after the market’s close. On Friday, shares of MELA Sciences Inc (NASDAQ:MELA) dropped -2.70% to close the day at $ 0.501. Company return on investment (ROI) is -291.60% and its monthly performance is recorded as -8.91%. MELA Sciences Inc (NASDAQ:MELA) quarterly revenue growth is -27.39%.